Viewing StudyNCT00116610



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00116610
Status: COMPLETED
Last Update Posted: 2009-01-21
First Post: 2005-06-29

Brief Title: Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Sponsor: Poniard Pharmaceuticals
Organization: Poniard Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Small Cell Lung Cancer
Keywords:
Name View
sensitive View
small cell lung cancer View
resistant View
refractory View
platinum View
chemotherapy View
second-line View
relapse View